SPAHQ Fall Conference: INSIGHT INTO OPIOIDS: FROM PRESCRIPTIONS TO BEHAVIORAL HEALTH
Deaths from drug overdoses have risen steadily over the past two decades and have become the leading cause of injury death in the United States. Prescription drugs, especially opioids, have been increasingly implicated in drug overdose deaths over the last decade. In response to recent increases in opioid-related morbidity and mortality, HHS has made addressing the opioid problem a priority. (Agency for HealthCare Research and Quality (AHRQ), https://www.ahrq.gov/opioids/whats-new.html ). We are fortunate to have two experts in the field Matthew Grissinger, RPH, FISMP, FASCP, Director of Error Reporting at the Institute for Safe Medication Practices, and Chris Mamrol, BSN, RN, CPPS, Behavioral Health Specialist at the Pennsylvania Patient Safety Authority present to SPAHQ. Come and learn with us as they provide us with their “Insights into Opioids”.
Click the links below to download the PowerPoint presentions:
- System Based Causes of Medication Errors
- Preventing Adverse Events with Opioids Using High Reliability Principles
- Strategies for Identification and Treatment of Substance Use
- Assessment of Inpatient Suicide Risk
Speaker: Christopher Mamrol, BSN, RN, CPPS
Patient Safety Liaison
Pennsylvania Patient Safety Authority
Christopher Mamrol is a Patient Safety Liaison with the Pennsylvania Patient Safety Authority for the Southeast region of Pennsylvania. Prior to joining the Authority, Christopher worked in an inpatient behavioral health hospital, serving in multiple roles, including managing multiple departments as the Safety & Quality Systems Director. Christopher earned his Bachelor of Science in Nursing from Drexel University. Christopher also has a Lean Six Sigma Black Belt certification through Villanova University and is a Certified Professional in Patient Safety.
Matthew Grissinger, RPh, FISMP, FASCP
Director of Error Reporting Programs
Institute for Safe Medication Practices (ISMP)
Matthew Grissinger, RPh, FISMP, FASCP is the Director of Error Reporting Programs at the Institute for Safe Medication Practices (ISMP). His responsibilities include working with healthcare practitioners and institutions to provide education about medication errors and their prevention, review medication errors that have been voluntarily submitted by practitioners to a national ISMP Medication Errors Reporting Program (MERP) as well as serving as a Manager of Medication Safety Analysis for the Pennsylvania Patient Safety Authority (PSA). Prior to joining ISMP, he served as a home care and long-term care pharmacy surveyor for the Joint Commission. Mr. Grissinger is a frequent speaker on pharmacy topics and current issues in medication safety. He contributes regular columns in P&T and the PSA Patient Safety Advisory and is a chapter contributor to a textbook published by McGraw-Hill entitled Pharmacy Management: Essentials for All Practice Settings, Essentials of Nurse Informatics, Remington and Medication Errors.
Mr. Grissinger serves as the chair of the National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP), the National Quality Form (NQF) Common Formats Expert Panel, the Editorial Board for P&T, the Faculty Advisory Board for the Pharmacy Learning Network (PLN) and the Publications Advisory Board for Davis’s Drug Guide for Nurses.
He is also an adjunct assistant professor for Temple University School of Pharmacy. Mr. Grissinger received a BS in Pharmacy from the Philadelphia College of Pharmacy and Science and is a fellow of the Institute for Safe Medication Practices as well as the American Society of Consultant Pharmacists.
Upon completion of the presentation, the participant will be able to:
- Identify system enhancements to prevent errors, detect errors before they reach the patient or minimize the consequences of medication errors.
- Identify effective strategies that can improve safety when prescribing, dispensing and administering opiates
- Discuss PA-HIIN project-specific activities to assist organizations in identifying risk with the use of opioids within their facilities
- Discuss strategies to improve suicide prevention practices
- Identify the occurrence and severity of substance use disorders
- Compare and contrast various strategies for the treatment of substance use disorders
Certificates of Attendance and Continuing Education Contact Hours will be awarded at the end of the Program on November 16, 2018 upon receiving an evaluation from each attendee.
This activity will be submitted to the National Association of Healthcare Quality for 6 CPHQ CE credit. The program content has been submitted for 6 clock hours by the State Board of Examiners of Nursing Home Administrators.